INNOVENT
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

INNOVENT Trademark

Serial Number: 88177424 • Registration: 6236173

INNOVENT is a trademark filed by Innovent Biologics (Suzhou) Co., Ltd. on November 1, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Innovent Biologics (Suzhou) Co., Ltd. (14 trademarks)

No. 168, Dongping Street
Suzhou City, Jiangsu Province , CN

Entity Type: 99

Trademark Details

Filing Date

November 1, 2018

Registration Date

January 5, 2021

Published for Opposition

October 20, 2020

Goods & Services

Medicines for human purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; pharmaceutical preparations, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; drugs in the nature of pharmaceutical preparations for medical purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; chemico-pharmaceutical preparations, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; chemical preparations for medical purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; injectable preparations for medical purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; biological preparations for medical purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; vaccines; diagnostic preparations for medical purposes; dietetic foods adapted for medical use; biological tissue cultures for medical purposes; nutraceutical preparations for use as a dietary supplement for therapeutic or medical purposes

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jan 5, 2026 REM1
REGISTERED-PRINCIPAL REGISTER
Jan 5, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 20, 2020 NPUB
PUBLISHED FOR OPPOSITION
Oct 20, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 30, 2020 NONP
1(B) BASIS DELETED; NEW BASIS REQUESTED
Sep 17, 2020 ADBS
NOTICE OF ALLOWANCE CANCELLED
Sep 17, 2020 IUCN
ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Sep 11, 2020 ATRQ
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Sep 11, 2020 PCBG
ASSIGNED TO PETITION STAFF
Sep 9, 2020 APET
TEAS PETITION TO AMEND BASIS RECEIVED
Jul 24, 2020 TPAD
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 16, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 21, 2020 NPUB
PUBLISHED FOR OPPOSITION
Apr 21, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 1, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 19, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 13, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 12, 2020 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 12, 2020 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 26, 2020 GNFN
FINAL REFUSAL E-MAILED
Feb 26, 2020 GNFR
FINAL REFUSAL WRITTEN
Feb 26, 2020 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 24, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 23, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 23, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 11, 2019 GNRN
NON-FINAL ACTION E-MAILED
Mar 11, 2019 GNRT
NON-FINAL ACTION WRITTEN
Mar 11, 2019 CNRT
ASSIGNED TO EXAMINER
Feb 7, 2019 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Nov 17, 2018 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 16, 2018 NWOS
NEW APPLICATION ENTERED
Nov 5, 2018 NWAP